AKWEL : A trend reversal can be anticipated
02/05/2019 | 05:16am EDT
Entry price :
16.7€ | Target : 21€ | Stop-loss : 14.5€ | Potential : 25.75%
The recent downside mouvement appears to lose momentum which could allow AKWEL shares to regain a positive medium term outlook. Investors have an opportunity to buy the stock and target the € 21.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria. In a short-term perspective, the company has interesting fundamentals.
The share is getting closer to its long-term support in weekly data, at EUR 14.7, which offers good timing for buyers. Predictions on business development from analysts polled by Thomson-Reuters are tight. This results from either a good visibility into core activities or accurate earnings releases. The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.43 for the 2018 fiscal year. Its low valuation, with P/E ratio at 5.9 and 5.18 for the ongoing fiscal year and 2019 respectively, makes the stock pretty attractive with regard to earnings multiples. The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
For the past year, analysts have significantly revised downwards their profit estimates. The underlying tendency is negative on the weekly chart below the resistance at 21.7 EUR
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.
1 123 M
Net income 2019
P/E ratio 2019
P/E ratio 2020
EV / Sales 2019
EV / Sales 2020
Number of Analysts
Average target price
Spread / Average Target
1st jan. Capitalization (M$)
AKWEL 14.29% 556